Amazentis

Amazentis is a life science company developing therapeutic nutrition products. Their products include Mitopure, a proprietary form of Urolithin A. Urolithin A is the end product created when bacteria in the gut break down ellagitannins, which are polyphenols found in fruits such as pomegranates, strawberries, walnuts, and raspberries. The substance does not appear naturally in its end form, so we normally rely on the beneficial bacteria in the gut microbiome to convert the polyphenols into urolithin A. In 2019, positive results from urolithin A human trial were reported and presumably Amazentis hopes to emulate those results with their allegedly purer proprietary form of Urolithin A.